BioAxone has developed a suite of selective ROCK2 inhibitors that avoid ... in-class biologic drug inhibits the small GTPase Rho, which is a key signaling molecule that affects regeneration ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback